NO20063867L - Hypokolesterolemisk sammensetning omfattende et staten og et antiflatulensmiddel - Google Patents

Hypokolesterolemisk sammensetning omfattende et staten og et antiflatulensmiddel

Info

Publication number
NO20063867L
NO20063867L NO20063867A NO20063867A NO20063867L NO 20063867 L NO20063867 L NO 20063867L NO 20063867 A NO20063867 A NO 20063867A NO 20063867 A NO20063867 A NO 20063867A NO 20063867 L NO20063867 L NO 20063867L
Authority
NO
Norway
Prior art keywords
antiflatulant
statins
plus
state
hypocholesterolemic
Prior art date
Application number
NO20063867A
Other languages
English (en)
Norwegian (no)
Inventor
Manuel M Raga
Antonio Guglietta
Marta Guerrero
Anna Orriols
Original Assignee
Ferrer Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferrer Int filed Critical Ferrer Int
Publication of NO20063867L publication Critical patent/NO20063867L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/695—Silicon compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biophysics (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Nutrition Science (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20063867A 2004-02-03 2006-08-30 Hypokolesterolemisk sammensetning omfattende et staten og et antiflatulensmiddel NO20063867L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04002317A EP1563837A1 (en) 2004-02-03 2004-02-03 Hypocholesterolemic compositions comprising a statin and an antiflatulent agent
PCT/EP2005/001038 WO2005074915A1 (en) 2004-02-03 2005-02-02 Hypocholesterolemic compositions comprising a statin and an antiflatulent agent

Publications (1)

Publication Number Publication Date
NO20063867L true NO20063867L (no) 2006-10-26

Family

ID=34684647

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20063867A NO20063867L (no) 2004-02-03 2006-08-30 Hypokolesterolemisk sammensetning omfattende et staten og et antiflatulensmiddel

Country Status (15)

Country Link
US (1) US20080206328A1 (es)
EP (2) EP1563837A1 (es)
JP (1) JP2007520514A (es)
KR (1) KR100815713B1 (es)
CN (1) CN101094667A (es)
AR (1) AR048668A1 (es)
AU (1) AU2005210117A1 (es)
BR (1) BRPI0507420A (es)
CA (1) CA2556181A1 (es)
NO (1) NO20063867L (es)
PA (1) PA8622701A1 (es)
PE (1) PE20050688A1 (es)
TW (1) TW200529818A (es)
UY (1) UY28729A1 (es)
WO (1) WO2005074915A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR1006879B (el) * 2005-09-14 2010-07-13 "Φαρματεν" Φαρμακευτικη Βιομηχανικη Εμπορικη Α.Ε., Βελτιωμενες φαρμακευτικες συνθεσεις που περιεχουν αναστολεις της αναγωγασης του 3-υδροξυ-3-μεθυλογλουταρυλοσυνενζυμου α (hmg-coa) και μεθοδος παρασκευης αυτων
AU2007245410A1 (en) 2006-04-26 2007-11-08 Rosemont Pharmaceuticals Ltd Liquid oral compositions
EP1928425B1 (en) * 2006-05-12 2013-01-23 Pharmathen S.A. Pharmaceutical formulation containing fluvastatin
CN101229187B (zh) * 2007-01-23 2011-09-28 德国柏林化学股份有限公司 西甲硅油乳剂及其制备方法
KR20150016280A (ko) * 2012-04-30 2015-02-11 에프. 호프만-라 로슈 아게 신규 제형

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4231938A (en) * 1979-06-15 1980-11-04 Merck & Co., Inc. Hypocholesteremic fermentation products and process of preparation
US4444764A (en) * 1979-08-06 1984-04-24 The Dow Chemical Company Phosphorus esters of alkylcycloalkyl-5-pyrimidinols and control of corn rootworm and western spotted cucumber beetle with them
DK149080C (da) * 1980-06-06 1986-07-28 Sankyo Co Fremgangsmaade til fremstilling af derivater af ml-236b-carboxylsyre
US4739073A (en) * 1983-11-04 1988-04-19 Sandoz Pharmaceuticals Corp. Intermediates in the synthesis of indole analogs of mevalonolactone and derivatives thereof
DE3322770C2 (de) * 1983-06-24 1985-10-03 Deutsche Gesellschaft für Wiederaufarbeitung von Kernbrennstoffen mbH, 3000 Hannover Vorrichtung zur Handhabung und zum Schutz von Lagergebinden für radioaktive Stoffe
FI94339C (fi) * 1989-07-21 1995-08-25 Warner Lambert Co Menetelmä farmaseuttisesti käyttökelpoisen /R-(R*,R*)/-2-(4-fluorifenyyli)- , -dihydroksi-5-(1-metyylietyyli)-3-fenyyli-4-/(fenyyliamino)karbonyyli/-1H-pyrroli-1-heptaanihapon ja sen farmaseuttisesti hyväksyttävien suolojen valmistamiseksi
US5177080A (en) * 1990-12-14 1993-01-05 Bayer Aktiengesellschaft Substituted pyridyl-dihydroxy-heptenoic acid and its salts
JP2648897B2 (ja) * 1991-07-01 1997-09-03 塩野義製薬株式会社 ピリミジン誘導体
AU7218294A (en) * 1993-07-06 1995-02-06 Mcneil-Ppc, Inc. H2 antagonist-alginate combinations
IL154068A0 (en) * 2000-07-27 2003-07-31 Teva Pharma Highly purified simvastatin compositions
CN1273112C (zh) * 2001-02-22 2006-09-06 斯凯伊药品加拿大公司 具有减少进食－禁食作用的贝特－它汀组合
US7101573B2 (en) * 2001-09-28 2006-09-05 Mcneil-Pcc, Inc. Simethicone solid oral dosage form
AU2003201735B2 (en) * 2002-01-11 2008-11-13 Circ Pharma Research And Development Limited Pravastatin pharmaceutical formulations and methods of their use
DE10209979A1 (de) * 2002-03-07 2003-09-25 Ratiopharm Gmbh Arzneimittel mit Cholesterolspiegel-senkenden Wirkstoffen mit zeitverzögerter Wirkstofffreisetzung
CA2379887C (en) * 2002-04-09 2004-01-20 Bernard Charles Sherman Stable tablets comprising simvastatin
WO2004021972A2 (en) * 2002-09-03 2004-03-18 Biovail Laboratories, Inc. Pharmaceuticals formulations and methods for modified release of statin drugs

Also Published As

Publication number Publication date
KR20060118579A (ko) 2006-11-23
UY28729A1 (es) 2005-03-31
AU2005210117A1 (en) 2005-08-18
JP2007520514A (ja) 2007-07-26
PE20050688A1 (es) 2005-10-14
WO2005074915A1 (en) 2005-08-18
AR048668A1 (es) 2006-05-17
EP1563837A1 (en) 2005-08-17
BRPI0507420A (pt) 2007-06-26
PA8622701A1 (es) 2005-08-10
TW200529818A (en) 2005-09-16
EP1713469A1 (en) 2006-10-25
KR100815713B1 (ko) 2008-03-20
CA2556181A1 (en) 2005-08-18
US20080206328A1 (en) 2008-08-28
CN101094667A (zh) 2007-12-26

Similar Documents

Publication Publication Date Title
BG105559A (en) STABLE PHARMACEUTICAL FORMULATION COMPRISING A HMG-CoA REDUCTASE INHIBITOR
NO20063867L (no) Hypokolesterolemisk sammensetning omfattende et staten og et antiflatulensmiddel
MX2007001553A (es) Nuevas composiciones farmaceuticas de estatina y metodos de tratamiento relacionados.
WO2000048626A3 (en) Aerosol compositions of hmg-coa reductase inhibitors for inhibiting inflammation associated with pulmonary disease
RS50419B (sr) Sastav koji ne poseduje askorbinsku kiselinu i koji sadrži inhibitor apsorpcije holesterola, hmg-coa reduktaze i stabilizujući agens
CA2324283A1 (en) Pharmaceutical composition containing a statin and aspirin
EP1314425A4 (en) MEDICINAL COMPOSITIONS FOR THE PREVENTION OR TREATMENT OF HEART FAILURE
IL174536A (en) Combination comprising candesartan and rosuvastatin, pharmaceutical compositions comprising such combination and use of such combination as a medicament for the prevention or treatment of atherosclerosis or cardiovascular events
IL190346A0 (en) Pharmaceutical preparation having excellent photostability
DK1626716T3 (da) Nitrooxyderivater af fluvastatin, pravastatin, cerivastatin, atorvastatin og rosuvastatin som cholesterol-sænkende midler med forbedret anti-inflammatorisk, antithrombotisk og anti-blodplade-aktivitet
WO2005103003A3 (en) Pyrrolopyridine derivatives and their use as hiv-integrase inhibitors
IE970731A1 (en) Product and method for the treatment of hyperlipidemia
BRPI0413468A (pt) inibidores de hmg-coa redutase baseados em pirrol
WO2002089788A3 (en) Pharmaceutical compositions comprising a hmg-coa reductase inhibitor
JP2007512347A5 (es)
DE60233899D1 (de) Neue boronatester
WO2000047196A3 (en) Use of statins for treating viral infections
JP2008063322A5 (es)
EP1275388A4 (en) TNF ALPHA INHIBITORS
RU2007148908A (ru) Составы для снижения риска возникновения вызванной лекарственными средствами аритмии
CA2529367A1 (en) Preventing atrial fibrillation (af) with the use of statin drugs
ATE264839T1 (de) Amino-thiolester-verbindungen, diese enthaltende pharmazeutische und kosmetische zusammensetzungen und ihre anwendungen
CA2375378A1 (en) Antilipemic combinations comprising hmg-coa reductase inhibitors and carnitines
NZ603397A (en) Association of xanthine oxidase inhibitors and statins and use thereof
EP1404313A4 (en) SIMVASTATIN METHYL ANALOGUES AS NEW HMG-CoA REDUCTASE INHIBITORS

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application